Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Infection|January 1, 1992
Spectrum and susceptibility of pathogens causing acute uncomplicated lower UTI in females and its correlation to bacteriologic outcome after single dose therapy with fosfomycin trometamol versus ofloxacin/co-trimoxazoleK G Naber, U Thyroff-Friesinger
Cardiology|January 1, 1990
Ibopamine versus digoxin in the treatment of mild congestive heart failure. A double-blind, randomized, placebo-controlled trialF X Kleber, U Thyroff-Friesinger
Infection|January 1, 1990
Fosfomycin trometamol versus ofloxacin/co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: a multicentre studyK G Naber, U Thyroff-Friesinger
Cardiology|January 1, 1990
Treatment of mild chronic congestive heart failure with ibopamine, hydrochlorothiazide, ibopamine plus hydrochlorothiazide or placebo. A double-blind comparative studyF X Kleber, U Thyroff-Friesinger
Pharmacological Research|September 1, 1996
Mefenamic acid bioequivalence assessment with a new statistical procedureA Rescigno, A Marzo, U Thyroff-Friesinger
Clinical Nephrology|October 30, 2009
Therapeutic equivalence, long-term efficacy and safety of HX575 in the treatment of anemia in chronic renal failure patients receiving hemodialysisM Haag-Weber, A Vetter, U Thyroff-Friesinger, et al.
International Journal of Clinical Pharmacology and Therapeutics|September 17, 2005
Bioequivalence studies with metformin: comparability of reference tablets from different originsV Vlahov, U Thyroff-Friesinger, R Koytchev, et al.
Transplantation Proceedings|June 27, 2003
Comparison of peak and trough level monitoring of cyclosporine treatment using two modern cyclosporine preparationsM Durlik, C Rauch, U Thyroff-Friesinger, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 29, 2009
Biosimilarity of HX575 (human recombinant epoetin alfa) and epoetin beta after multiple subcutaneous administrationF Sörgel, U Thyroff-Friesinger, A Vetter, et al.
Cardiology|January 1, 1992
Ibopamine as a valuable adjunct and substitute for dopamine in bridging therapy before heart transplantationF X Kleber, G V Sabin, U Thyroff-Friesinger, et al.
Pageof 2